Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the cost of the Shingrix vaccine in India, factors influencing its price, and potential financial assistance options. Understand its importance in preventing shingles.
Shingles, also known as herpes zoster, is a painful rash caused by the varicella-zoster virus, the same virus that causes chickenpox. While chickenpox is usually a mild childhood illness, the varicella-zoster virus can remain dormant in the body for decades and reactivate later in life as shingles. This reactivation can lead to a painful, blistering rash, often accompanied by nerve pain that can persist long after the rash has cleared. In India, like in many other countries, the Shingrix vaccine is a crucial tool for preventing shingles, especially in adults aged 50 and above, and in individuals with weakened immune systems. However, understanding the cost associated with this vaccine is essential for making informed healthcare decisions.
Shingrix is a recombinant zoster vaccine (RZV) developed by GSK. It is designed to help prevent shingles in adults aged 50 years and older. It is also recommended for adults 19 years of age and older who have or will have weakened immune systems due to disease, medication, or other causes. Unlike live attenuated vaccines, Shingrix is a non-live vaccine, meaning it contains specific components of the virus rather than the whole, weakened virus. This makes it a safer option for individuals with compromised immune systems.
Shingrix works by stimulating the body's immune system to produce a strong response against the varicella-zoster virus. It contains an adjuvant, a substance that helps to boost the immune response, ensuring that the body builds robust protection against shingles. The vaccine is administered in two doses, with the second dose given two to six months after the first dose. A complete vaccination series is crucial for optimal protection.
While specific nationwide statistics on shingles prevalence in India can be challenging to pinpoint, it is understood that the incidence of shingles increases significantly with age. As the Indian population ages, the number of individuals at risk for shingles is also growing. Shingles can have a profound impact on an individual's quality of life, causing severe pain, discomfort, and potential long-term complications such as postherpetic neuralgia (PHN), vision problems (if it affects the eye), and even neurological issues. The economic burden of shingles, including medical costs and lost productivity, can also be substantial.
The cost of the Shingrix vaccine in India can vary significantly depending on several factors:
As of recent information, the approximate cost of a single dose of Shingrix in India can range from ₹8,000 to ₹12,000 or more. Since two doses are required for complete vaccination, the total cost for the Shingrix vaccine series can range from approximately ₹16,000 to ₹24,000 or higher. These are estimates, and the actual price may vary.
The price of Shingrix is influenced by the research and development costs, manufacturing processes, quality control measures, and the adjuvant technology used in its formulation. The vaccine's efficacy and safety profile also contribute to its value and, consequently, its price. The distribution network and logistical costs involved in maintaining the cold chain for vaccine storage and transport also play a role.
For individuals concerned about the cost of Shingrix, exploring financial assistance options is important:
It's important to note that Shingrix is a newer and generally more effective vaccine compared to Zostavax, an older live attenuated vaccine for shingles. While Zostavax might have been available at a lower cost, Shingrix has demonstrated higher efficacy in clinical trials, particularly in preventing shingles and its complications like PHN. The decision between vaccines, if both are available, should be made in consultation with a healthcare provider, considering factors like age, health status, and vaccine effectiveness.
It is highly recommended to consult with your doctor to determine if the Shingrix vaccine is appropriate for you. Your doctor will consider your age, medical history, current health status, and any potential contraindications. They can provide personalized advice on the benefits of vaccination, the recommended schedule, and potential side effects. Discussing the cost and available options for obtaining the vaccine with your doctor or a healthcare provider at the clinic is also a crucial step.
Yes, Shingrix is available in India and is approved for use in adults aged 50 years and older, and for adults 19 years and older who are immunocompromised.
The Shingrix vaccination series consists of two doses, administered intramuscularly. The second dose should be given 2 to 6 months after the first dose.
Common side effects include pain, redness, and swelling at the injection site, as well as fever, headache, fatigue, and muscle pain. These side effects are usually mild to moderate and resolve within a few days.
Yes, Shingrix can be given to individuals who have had shingles in the past. It is recommended to wait until the shingles rash has cleared and any acute symptoms have resolved before getting vaccinated.
Coverage varies by insurance provider and policy. It is essential to check with your specific health insurance company to determine if Shingrix is covered.
Shingrix is available at many private hospitals, clinics, and vaccination centers across India. Your doctor can guide you on where to get vaccinated.
Preventing shingles through vaccination is a significant step towards maintaining long-term health and well-being, especially for older adults and those with compromised immune systems. While the cost of the Shingrix vaccine in India represents a considerable investment, understanding the pricing, potential financial assistance options, and the vaccine's proven benefits can help individuals make informed decisions. Consulting with healthcare professionals is paramount to ensure appropriate vaccination and to navigate the process of obtaining the vaccine effectively.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026